Pre-clinical and Clinical Safety Studies of CMX-2043: a cytoprotective lipoic acid analogue for ischaemia-reperfusion injury.
about
Pre-clinical and Clinical Safety Studies of CMX-2043: a cytoprotective lipoic acid analogue for ischaemia-reperfusion injury.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pre-clinical and Clinical Safe ...... ischaemia-reperfusion injury.
@ast
Pre-clinical and Clinical Safe ...... ischaemia-reperfusion injury.
@en
Pre-clinical and Clinical Safe ...... ischaemia-reperfusion injury.
@nl
type
label
Pre-clinical and Clinical Safe ...... ischaemia-reperfusion injury.
@ast
Pre-clinical and Clinical Safe ...... ischaemia-reperfusion injury.
@en
Pre-clinical and Clinical Safe ...... ischaemia-reperfusion injury.
@nl
prefLabel
Pre-clinical and Clinical Safe ...... ischaemia-reperfusion injury.
@ast
Pre-clinical and Clinical Safe ...... ischaemia-reperfusion injury.
@en
Pre-clinical and Clinical Safe ...... ischaemia-reperfusion injury.
@nl
P2093
P2860
P356
P1476
Pre-clinical and Clinical Safe ...... ischaemia-reperfusion injury.
@en
P2093
Alan S Lader
Ralph Casale
Reinier Beeuwkes
Steven A Kates
P2860
P304
P356
10.1111/BCPT.12254
P577
2014-05-16T00:00:00Z